SEARCH RESULTS

330029 RESULTS

Medical Foods—Fallback Option for Elusive AD Drug Status?

RESEARCH NEWS 2009-10-14 Research News Two years ago, iffy results from a massive Phase 3 trial led a Canadian drug company to scrap development of its anti-amyloid therapy for Alzheimer disease. Today, seniors can purchase the very same compound, rebranded as a “science-based na

Paris: Macro-roles for MicroRNAs in the Life and Death of Neurons

CONFERENCE COVERAGE 2009-10-14 Conference Coverage Adapted from an original article by Jennifer Altman in the September-October issue of Alzheimer Actualités, a newsletter published in French by the Ipsen Foundation. The Alzforum editors acknowledge the Foundation’s generosity in makin

Dimebon: Bright Star or Black Hole?

RESEARCH NEWS 2009-10-14 Research News Dimebon appears as one bright light in a field of less-than-stellar clinical trial results of late. But like many stars that suddenly explode into view, is the compound destined to become a black hole? While the drug appeared to stave off cl

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE